SEP 9, 2026 · PHASE 2 TRIAL
A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
ClinicalTrials.gov
This is an active Phase 2 trial registration with no reported results; it describes a planned study of a combination approach in triple-negative breast cancer with a metabolic biomarker as primary outcome.
Reported
Planned enrollment55
Study phasePhase 2
Primary outcome measureChange in insulin resistance scores (HOMA-I…